GOLDEN PHARMACEUTICALS INC
10KSB, 1995-12-12
PHARMACEUTICAL PREPARATIONS
Previous: KIDDER PEABODY CASH RESERVE FUND INC, 497, 1995-12-12
Next: GOLDEN PHARMACEUTICALS INC, 10KSB, 1995-12-12



[TYPE] 10-KSB
[ARTICLE] 5
[LEGEND]
This schedule contains summary financial information extracted from the
registrants financial statements for the year ended August 31, 1995 contained in
its annual report on Form 10-KSB and is qualified in it's entirety by
reference to such financial statements.
[/LEGEND]
<TABLE>
<S>                             <C>                     <C>
[PERIOD-TYPE]                   YEAR                   YEAR
[FISCAL-YEAR-END]                          AUG-31-1995             AUG-31-1994
[PERIOD-END]                               AUG-31-1995             AUG-31-1994
[CASH]                                          49,557                  94,792
[SECURITIES]                                         0                       0
[RECEIVABLES]                                1,484,175                 310,307
[ALLOWANCES]                                  (63,700)                 (1,063)
[INVENTORY]                                    674,955                  52,356
[CURRENT-ASSETS]                             2,656,600                 952,584
[PP&E]                                       2,736,714               2,052,181
[DEPRECIATION]                             (1,659,768)             (1,555,033)
[TOTAL-ASSETS]                               8,079,905               1,515,489
[CURRENT-LIABILITIES]                        2,040,931                 428,703
[BONDS]                                              0                       0
[COMMON]                                    21,288,851              21,246,351
[PREFERRED-MANDATORY]                                0                       0
[PREFERRED]                                    292,558                 292,558
[OTHER-SE]                                (20,469,509)            (21,359,368)
[TOTAL-LIABILITY-AND-EQUITY]                 8,079,905               1,515,489
[SALES]                                      4,412,377               3,451,020
[TOTAL-REVENUES]                             4,412,377               3,451,020
[CGS]                                        2,245,230               1,584,864
[TOTAL-COSTS]                                2,245,230               1,584,864
[OTHER-EXPENSES]                             1,255,645               1,037,502
[LOSS-PROVISION]                                     0                       0
[INTEREST-EXPENSE]                             140,330                  83,949
[INCOME-PRETAX]                                787,303                 752,552
[INCOME-TAX]                                  (91,594)               (500,000)
[INCOME-CONTINUING]                            878,897               1,252,552
[DISCONTINUED]                                       0                       0
[EXTRAORDINARY]                                 99,677                  76,560
[CHANGES]                                            0                       0
[NET-INCOME]                                   978,574               1,329,112
[EPS-PRIMARY]                                      .01                     .01
[EPS-DILUTED]                                      .01                     .01
</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission